Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-12 07:23 am Purchase | 13G | KYVERNA THERAPEUTICS INC KYTX | Westlake BioPartners Fund I L.P. | 4,523,924 10.500% | 4,523,924 (New Position) | View |
| 2024-10-10 12:36 pm Purchase | 13G | KYVERNA THERAPEUTICS INC KYTX | JPMORGAN CHASE & CO JPM | 2,380,021 5.500% | 2,380,021 (New Position) | View |
| 2024-05-03 5:57 pm Purchase | 13D | KYVERNA THERAPEUTICS INC KYTX | Vida Ventures LLC | 4,777,060 11.100% | 4,777,060 (New Position) | View |
| 2024-02-22 4:29 pm Purchase | 13G | KYVERNA THERAPEUTICS INC KYTX | Northpond Ventures III LP | 3,255,426 7.600% | 3,255,426 (New Position) | View |
| 2024-02-20 4:31 pm Purchase | 13G | KYVERNA THERAPEUTICS INC KYTX | GILEAD SCIENCES INC. GILD | 4,126,119 9.600% | 4,126,119 (New Position) | View |
| 2024-02-14 5:20 pm Purchase | 13G | KYVERNA THERAPEUTICS INC KYTX | Bain Capital Life Sciences Opportunities III LP | 3,163,868 7.400% | 3,163,868 (New Position) | View |